Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders - MarketWatch -BoardProspects

Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders

MarketWatch Mar 25 2019 BoardNews

Bristol-Myers Squibb Company’s BMY, -1.55% Board of Directors today sent an open letter to the Company’s shareholders regarding the previously announced definitive merger agreement with Celgene Corporation CELG, -1.65% In addition to its March 19 investor presentation, the Company today also made available on Bristol-Myers Squibb’s website ...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Tensions with the Board Not the Norm, Say 98 Percent of CEOs also categorized in BoardNews
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Corporate Governance Best Practices also categorized in BoardNews
- Still few women on boards also categorized in BoardNews
- T-Mobile and Sprint Inch Closer to a Merger also mentions Merger
- Executive Compensation: What Will 2012 Bring? — The Harvard Law School Forum on Corporate Governance and Financial Regulation also categorized in BoardNews
- Questions Every Board Director Needs to Ask about Technology also published in MarketWatch
- Fortune 500 Directors Emphasize Digital Communication Strategies ... also published in MarketWatch
- Cracker Barrel Holders Reject Biglari's Bid for Seat also categorized in BoardNews
- 2011 Annual Corporate Governance Review — The Harvard Law School Forum on Corporate Governance and Financial Regulation also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
Topics Mentioned